Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122122 · ClinicalTrials.gov registry record · Phase 3
Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
NCT00122122 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 600 participants.
The verdict
NCT00122122, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
Study Summary
Complications resulting from medications, or adverse drug events (ADEs), are prevalent and are a major source of excess morbidity and costs. ADEs are particularly problematic in older patients because of their higher burden of comorbidity and diminished physiologic reserve. In addition, older patients are more likely to be exposed to polypharmacy, a major risk factor for ADEs. While ADEs may be idiosyncratic, many result from medical errors and inadequate systems for ensuring the safe and effective use of medications. The goal of the proposed study is to test the efficacy of a potentially potent intervention to improve the use of medications in older outpatients enrolled in VA primary care clinics. The intervention-Enhanced Pharmacy Care-involves a formal, multi-dimensional evaluation of patients� medication regimens by a trained clinical pharmacist and board-certified geriatrician.
Interventions
- BEHAVIORAL Enhanced Pharmacy Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Est. Completion | 2004-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00122122
The ClinicalTrials.gov registry entry for NCT00122122 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhanced Pharmacy Care is the first listed.
NCT00122122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00122122 about?
NCT00122122 is a clinical study titled "Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients". Complications resulting from medications, or adverse drug events (ADEs), are prevalent and are a major source of excess morbidity and costs. ADEs are particularly problematic in older patients because of their higher burden of comorbidity and diminished physiologic reserve. In addition, older patien...
What is the current status of trial NCT00122122?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 600 participants. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00122122?
The interventions under investigation include: Enhanced Pharmacy Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00122122?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.